The Astroskin Vital Signs Monitoring Platform is an advanced smart clothing used in Space and on Earth for cutting-edge research and projects. Join us live on March 30th at 11:00 am EDT, and meet our speakers to learn more about current and future projects with Astroskin.
Hexoskin will provide a demonstration of the capabilities of the industry-leading Hexoskin smart clothing, an advanced wearable technology that integrates ECG, RIP, & Activity sensors in a comfortable smart garment.
Register to reserve your place today. Registration is Free!
Hexoskin's CEO Pierre-Alexandre Fournier joined astronaut David Saint-Jacques and other panelists this week to discuss innovation in space medicine at the Virtual MedTech Conference.
After 20 years of continuous human presence on the International Space Station, countries from around the world are getting ready to send humans farther into our solar system, beyond Earth's orbit. Technologies required to support long-duration missions, such as to Mars and back to the moon, will be critical to the next 50 years of space exploration.
The Canadian Space Agency, numerous innovative Canadian medical technology companies and the National Research Council of Canada, are performing key research to develop and incorporate novel medical devices solutions for long-duration human spaceflight.
Cutting-edge microgravity research and space-relevant clinical expertise are critical to ensure an autonomous crew health care system. Canadian scientists, clinicians and specialists have developed and demonstrated new devices for remote clinical care including point of care diagnostics and real-time astronaut monitoring.
Among these innovations, Hexoskin has launched the wearable Astroskin Bio-Monitor system to the International Space Station in 2018 to monitor astronaut's vital signs. The system is used since for medical research in micro-gravity but also for research on Earth by a wide community of clinicians working in universities and research centers around the world.
The video of the MedTech Conference panel has been published and is available on the conference platform for attendees here: https://medtechvirtual2020.pathable.co/meetings/virtual/v98noBALBh3R4Xa5e
To learn more on Astroskin Vital Signs Monitoring Platform, Download Astroskin Product Specifications or contact us.
We thank all our attendees and Guests Speakers who participated in our Live Webinar on Continuous & Remote Respiratory Monitoring with Hexoskin - In the Era of Chronic Illness, Pandemics & Limited Health Resources, on August 25th, 2020! If you were not able to attend live, and wish to watch it, you can now access the Webinar's recording:
Over 250 guests registered for this panel with our guest speakers Dr. Dennis Jensen (McGill University), and Denise Mannée (Radboud University Medical Center). In this session we discussed the benefits and considerations of digital technologies for Healthcare Providers, Researchers and Patients, and provide real-world evidence of Hexoskin's remote respiratory monitoring capabilities.
If you couldn't attend, and wish to watch it, you can now request access to the Webinar's recording. Thank you for your interest and feel free to reach out if you have any questions.
The introduction of digital technologies has promulgated innovative platforms aimed at reducing the gaps in respiratory disease management and research. How are they used? How can we distinguish effective programs from the hundreds of available digital solutions? This webinar will discuss the benefits and considerations of digital technologies for Healthcare Providers, Researchers and Patients, and provide real-world evidence of Hexoskin's remote respiratory monitoring capabilities.
Join us with our guest speakers on Tuesday, August 25, 2020, at 11:00 AM (EDT), for the upcoming Hexoskin Live Webinar on Continuously & Remote Respiratory Monitoring. If you are unable to attend, you can still register and we will send you the recorded webinar by email afterwards.
Guest Speakers:
Moderator:
We look forward to your presence for this special event!
Today is COPD day. World Chronic Obstructive Pulmonary Disease Day (COPD) is celebrated on the third Wednesday of November every year, in collaboration with health experts, research foundations and patients with COPD.
COPD is not one single disease but an umbrella term used to describe chronic lung diseases that cause limitations in lung airflow. COPD is a life-threatening disease in advanced cases. It is an under-diagnosed and life-threatening lung disease, leading cause of death in the United States, affecting 16 million Americans and millions more who don’t know they have it.
Help support research and education by giving to the COPD Foundation that undertakes daily initiatives to improve the lives of individuals affected by COPD, and expand care services for COPD. The Foundation’s activities focus on achieving these results through education and advocacy programs and research that will lead to prevention, and someday, a cure for this disease.
About Hexoskin:
Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. The Hexoskin platform is an end-to-end software system to monitor and analyse users' general health, vital signs, sleep, and activity, using built-in sensors embedded in smart garments made in Canada.
The Hexoskin smart clothing and Hexoskin Connected Health Platform has been used to collect data for over 80 scientific publications in the fields of cardiology, respiratory, behavioural & physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning.
Hexoskin is attending this week the Québec Respiratory Health Annual Congress (Congrès Québécois en Santé Respiratoire) of the Quebec Lung Association, on October 24 & 25, 2019 at the Montréal Science Center.
The Hexoskin team will meet with specialists, researchers and many stakeholders in Respiratory and Pulmonary Health. Our team will present its Connected Health Platform and its expertise for remote monitoring of patients with respiratory diseases from the comfort of their homes.
At Hexoskin, we're committed to work with organizations like the Québec Lung Association (APQ), American College of Chest Physicians, American Thoracic Society (ATS), COPD Foundation, the American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR), the American Heart Association (AHA), the Alliance for Artificial Intelligence in Healthcare (AAIH) and many others to develop new standards of care for these chronic patients.
If you're a Pharma, a Medical company or a Healthcare provider interested in patient remote monitoring with digital markers, sensors, and AI, please contact us.
About Hexoskin
Founded in 2006 in Montreal, Hexoskin (Carré Technologies) is involved in the development of non-invasive sensors, software and applications, data science services and AI. Hexoskin's mission is to record and categorize personal health information, to make it accessible and useful.
Hexoskin is attending the Chest Annual Meeting on October 19-23, 2019 in New Orleans.
The Hexoskin Team will be meeting with Chest Physicians and multiple stakeholders from Lung Health and Clinical Chest Medicine. Our team will showcase its Connected Health Platform and expertise for monitoring patients with chronic respiratory & cardiac diseases remotely, from the comfort of their home.
If your company is interested in digital markers, sensors and AI in healthcare, book a meeting with our team y contacting us.
View full article →
Hexoskin has been working for many years with rehabilitation professionals to provide more insights about patients recovering at home. The 34th American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) Annual Meeting in Portland (OR) on September 18-21 will be another great opportunity to connect with the experts who make rehabilitation easier for patients!
AACVRP is home for Cardiovascular and Pulmonary Rehabilitation professionals, where they discuss and promote experiences, challenges, advances and research. We are looking forward to working with a diverse group of heart, respiratory and rehabilitation care specialists to explore new paths to deliver cutting-edge science that keeps patients in the comfort of their home.
The Hexoskin Team will be hosting meetings at the Oregon Convention Center in Portland, Oregon. Our team will be presenting demos of its new clinically validated collection of Smart Garments for remote patient monitoring along with the Hexoskin Connected Health Platform, already used for rehabilitation and health research in cardiology, pulmonology, psychiatry, rare diseases and many other health conditions.
Keep patients at home. Make patients healthier. That's what professionals working in cardiac rehabilitation and pulmonary rehabilitation do. All year long. Hexoskin helps them get data about their patients and answer these questions:
This helps rehabilitation professionals personalize their approach and provide services to patients remotely. Almost every patient should be in a cardiac rehab program after a heart attack. Currently, in the US and Canada, less than 20% of eligible patients participate in a cardiac rehab program. For pulmonary rehab (COPD patients), it's less than 4%! This low participation rate is costing Medicare billions of dollars in additional hospitalization fees. Most importantly, millions of patients are not getting the care that would keep them out of the hospital. We need to make cardiac and pulmonary rehabilitation more accessible. That's why we'll be in Portland this week.
About Hexoskin
Founded in 2006 in Montreal, Hexoskin (Carré Technologies Inc.) is involved in the development of non-invasive sensors, software & applications, data science & AI services. Hexoskin’s mission is to record and organize personal health information and make it accessible and useful.
On September 12th this week, Hexoskin's Co-founder & CTO Jean-François Roy will discuss sensors, data, and AI in medicine at the Intelligent Health AI conference in Basel, Switzerland.
Hexoskin has been chosen among only 5 companies in the world to present at the Showcase event at the conference sponsored by Novartis. Hexoskin's Chief Technology Officer Jean-François Roy will present new opportunities for healthcare and pharmaceutical organizations to uncover new insights from the data they have collected from clinical trials.
Artificial Intelligence and Machine Learning have the potential to transform drug development and reduce the time to market of much-needed therapies in various therapeutic areas, including rare diseases, and find new cures for millions of patients.
The Hexoskin end-to-end data platform is secure and platform agnostic. Hexoskin's clients have access to cost-effective tools to manage clinical studies, collect rich health data, and build unique databases and datasets for machine learning & AI projects.
Hexoskin has a dedicated group of AI & biomedical researchers with years of experience in preparing and analyzing health data, and in the development of machine learning algorithms with health data. Its research team collects new vital signs data and use external datasets to answer novel research questions.
About Hexoskin:
Founded in 2006 in Montreal, Hexoskin is the leader in non-invasive sensors, smart clothing, software, data science & AI services. Hexoskin launched in 2013 the first washable smart shirts that capture cardiac, respiratory, and activity body metrics. The Hexoskin platform is an end-to-end software system to monitor and analyse users' general health, vital signs, sleep, and activity, using built-in sensors embedded in smart garments made in Canada.
The Hexoskin smart clothing and Hexoskin Connected Health Platform has been used to collect data for over 70 scientific publications in the fields of cardiology, respiratory, behavioural & physiological psychology, sleep patterns, circadian rhythms, effects of aging on physical performance, and AI-Machine Learning. The company provides custom solutions, R&D project management, and services to international clients including pharmaceuticals, research centers, government agencies, and healthcare providers.